OFFICIAL PUBLICATION OF

by its subsidiary APPco

New COVID medicine listing

Sheshtyn Paola 11/04/2022

Oral antiviral Paxlovid to be added to the PBS from 1 May as a treatment for COVID-19 Community pharmacists can expect to see PBS-subsidised scripts of the oral anti-viral medicine Paxlovid (nirmatrelvir and ritonavir) from 1 May 2022. Paxlovid is a prescription-only medicine that can be used by patients with mild-moderate COVID-19 who have a

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

New COVID medicine listing

Previous "We've been so inspired by watching everyone rise to the challenge"

Next Taking vaccination to the people

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous "We've been so inspired by watching everyone rise to the challenge"

Next Taking vaccination to the people

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.